Marché des réactifs q-PCR en Arabie saoudite – Tendances et prévisions de l’industrie jusqu’en 2030

Analyse et perspectives du marché des réactifs q-PCR en Arabie saoudite

La sensibilisation croissante du public aux maladies chroniques et transmissibles a accru la demande sur le marché. Les principaux acteurs du marché se concentrent sur le lancement et l'approbation de divers produits au cours de cette période cruciale. En outre, l'augmentation des technologies améliorées et avancées contribue également à la demande croissante du marché.

Le marché des réactifs q-PCR en Arabie saoudite devrait croître au cours de la période de prévision de 2023 à 2030 en raison de l'augmentation des maladies chroniques. Le financement élevé des activités de recherche par le gouvernement et d'autres organismes devrait également stimuler la croissance du marché. Parallèlement à cela, les fabricants sont engagés dans des activités de R&D pour lancer de nouveaux produits sur le marché. Cependant, le coût élevé des produits devrait freiner la croissance du marché. La demande croissante de soins de santé de meilleure qualité pour les troubles transmissibles et l'adoption croissante de la médecine personnalisée devraient stimuler la croissance du marché. Cependant, les obstacles opérationnels rencontrés dans la réalisation de tests de diagnostic devraient remettre en cause la croissance du marché.

Data Bridge Market Research analyse que le marché saoudien des réactifs q-PCR devrait atteindre une valeur de 41 798,44 milliers USD d'ici 2030, à un TCAC de 8,3 % au cours de la période de prévision de 2023 à 2030.

Définition du marché

q-PCR reagents are used in the simultaneous amplification and detection/quantification of nucleic acids using the polymerase chain reaction (PCR). These reagents are used in different applications such as research, diagnosis, and forensics. They are also used for the detection of viruses, genetic stability testing, and others. The main advantage of qPCR is that it allows you to determine the initial number of copies of template DNA (the amplification target sequence) with accuracy and high sensitivity over a wide dynamic range.

Saudi Arabia q-PCR Reagents Market Dynamics

This section deals with the understanding of market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

• Increasing Prevalence of Chronic and Communicable Diseases

Chronic diseases include cardiac diseases, cancer, and diabetes, which are the leading causes of death and disability in many countries around the globe. q-PCR reagents are essential for the diagnosis of chronic diseases such as human Immuno Deficiency Virus (HIV) and malaria. Both conditions have non-specific symptoms. The q-PCR kits and mixers contain all the necessary PCR reagents for rapid, sensitive, and reproducible real-time detection of HIV and other diseases using highly specific primer pairs.

• Increase in Geriatric Population

The geriatric population is susceptible to chronic and malignant diseases. The non-specific antibodies are more common in the elderly population. The diagnosis through q-PCR reagents is important for the elderly population as it provides early diagnosis which is crucial to prevent the extensive spread of the disease since the test is non-invasive and aids in determining antigen detection in infectious chronic diseases. Since the geriatric population is increasing, the need for q-PCR reagents will also increase.

Restraint

• Stringent Rules and Regulation

The commercialization of reagents and products by various key market players is facilitated by compliance with the regulatory frameworks established in the country. The rapid development of privacy policies and regulations being made by SFDA is restraining the market growth. The regulatory authority in charge of regulating the registration and endorsement of medical equipment, including PCR reagents, in Saudi Arabia is known as the Saudi Food and Drug Authority. The SFDA has rules for product registration, labeling, and quality control that manufacturers and distributors of PCR reagents must follow, which restrains market growth.

Opportunity

• Rise in Government Funding for Healthcare

The government, federations, and major market players are creating opportunities across developing countries. These initiatives by the players and government are helping the users to reach out to take advantage of the policies made for low-income and developing nations and making them aware of the diseases that are preventable if diagnosed earlier.

Investments in medical R&D may increase as healthcare spending rises. More studies are conducted in the areas of genetic research, illness monitoring, and diagnostics, which may increase demand for q-PCR reagents. Healthcare facilities may increase the number and type of clinical tests they offer as they develop and enhance their services, which provides the opportunity for market growth.

Challenge

• Lack of Skilled Workforce

q-PCR technology is continuously advancing and manufacturers are continuously engaged in R&D activities for launching advanced q-PCR which require highly skilled and certified professionals to operate it. Handling reagents and maintaining the PCR reactions is not a simple task. It is a vast process that requires proper knowledge, and experience so that the result conducted will be accurate and proper. However, this shortage in the professional and skilled workforce has decreased the market for q-PCR reagents.

The requirement for skilled and certified professionals is a big challenge for the market. The q-PCR is a complex process and the devices have advanced features that require skilled professionals to operate them to provide safe such as effective services to patients.

Recent Developments

• In December 2021, Thermo Fisher Scientific Inc. announced that they have completed the acquisition of PPD, Inc. a leading Saudi Arabia provider of clinical research services to the biopharma and biotech industry. This acquisition has helped the company to increase its product portfolio and sales.
• In September 2021, Agilent Technologies, Inc. announced the signing of a worldwide distribution agreement with Visiopharm, enabling Agilent to co-market Visiopharm’s portfolio of CE-IVD marked artificial intelligence (AI)-driven precision pathology software and other products. This has increased the company’s product reach.
• In September 2021, Bio-Rad Laboratories, Inc. announced the partnership with Seegene, Inc., a Saudi Arabia leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products. This has increased the company’s product portfolio.
• In June 2021, Agilent Technologies, Inc. announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma industry which include instruments, columns, reagents, and supplies that seamlessly integrate with Agilent OpenLab and MassHunter software, and CrossLab services to maximize efficiency in biopharma labs. This has increased the company’s sales and product portfolio.
• In July 2020, Thermo Fisher Scientific Inc. announced the launch of the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes. This has increased the company’s revenue and product portfolio.

Saudi Arabia q-PCR Reagents Market Scope

Le marché des réactifs q-PCR en Arabie saoudite est segmenté en quatre segments notables en fonction du type, de l'application, de l'utilisateur final et du canal de distribution. La croissance entre les segments vous aide à analyser les niches de croissance et les stratégies pour aborder le marché et déterminer vos principaux domaines d'application et la différence entre vos marchés cibles.

Taper

• Réactifs
• Consommables

Sur la base du type, le marché est segmenté en réactifs et consommables.

Application

• Clinique
• Recherche
• Tests de sécurité des produits alimentaires
• Médecine légale
• Autres

Sur la base des applications, le marché est segmenté en tests cliniques, recherche, tests de sécurité des produits alimentaires, criminalistique et autres.

Utilisateur final

• Hôpitaux
• Centres de diagnostic
• Sociétés pharmaceutiques et biopharmaceutiques
• Institut de recherche et d'enseignement
• Organisation de recherche clinique
• Laboratoires vétérinaires
• Laboratoires médico-légaux
• Autres

Sur la base de l'utilisateur final, le marché est segmenté en hôpitaux, centres de diagnostic, sociétés pharmaceutiques et biopharmaceutiques, instituts de recherche et universitaires, organismes de recherche clinique, laboratoires vétérinaires, laboratoires médico-légaux et autres.

Canal de distribution

• Appel d'offres direct
• Ventes au détail
• Autres

Sur la base du canal de distribution, le marché est segmenté en appels d'offres directs, ventes au détail et autres.   

Analyse du paysage concurrentiel et des parts de marché des réactifs q-PCR en Arabie saoudite

Le paysage concurrentiel du marché des réactifs q-PCR en Arabie saoudite fournit des détails sur les concurrents. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements en R&D, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement du produit, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et l'ampleur du produit, la domination des applications et la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise sur le marché des réactifs q-PCR en Arabie saoudite.

Certains des principaux acteurs du marché opérant sur le marché des réactifs q-PCR en Arabie saoudite sont F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Quantabio, Sino Biological Inc., QIAGEN, TAKARA HOLDINGS INC, Enzo Biochem Inc., meridian BIOSCIENCE, Tonbo Biosciences (une filiale de Cytek Biosciences), Norgen Biotek Corp., entre autres.

SKU-70246